IP Library Granted Patent US 10,413,286
Granted Patent B2
US 10,413,286 · App. 13/471,415 · Granted Sep 17, 2019

Intra-atrial implants having variable thicknesses to accommodate variable thickness in septum

Inventors: Edward McNamara (Chelmsford, MA); David Celermajer (Vaucluse, AU); Stephen J. Forcucci (Winchester, MA); Hiroatsu Sugimoto (Cambridge, MA)
Assignee: CORVIA MEDICAL, INC.
A61B17/02A61B17/0057A61F2/06A61F2/24A61F2/2412A61F2/2442A61F2/2475A61M27/002A61B2017/00252A61B2017/00575A61B2017/00592A61B2017/00606A61B2017/00867A61B2017/0237
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,413,286
App. No.
13/471,415
Granted
Sep 17, 2019
Kind
B2
Abstract

The invention is a septal implant that can accommodate variable thicknesses of the patient's atrial septum as well the variable thicknesses of septums across a population. The invention is able to accomplish this result by having flexible annular flanges that define a gap into which the septum fits. Due to the flexible nature of the annular flanges, the gap is adjustable.

Claims (17)

1. A device for directing blood flow across in the atrial septum in a heart of a patient, the device comprising: a. a core segment having a length greater than the atrial septum and defining a passage, the core segment having a first diameter when deployed; b. a first flexible annular flange joining a first end of the core segment, wherein the first flexible annual flange is configured to form a substantially flat surface that contacts one side of the atrial septum, forming a first contacting surface; and c. a second flexible annular flange joining a second end of the core segment; wherein a distal portion of the second flexible annular flange is formed to lie at a parallel angle to and to contact the other side of the atrial septum, forming a second contacting surface, and wherein the first contacting surface is greater than the second contacting surface; a flow control element attached to the core segment, wherein the device is collapsible, enabling the core segment to have a second diameter less than the first diameter thereby enabling percutaneous delivery of the device to the heart of the patient, wherein at least a portion of the first and second annular flanges define an annular gap, and wherein said annular gap is smaller than the length of the core segment.

2. The device of claim 1 wherein the annular gap is has a width less than a thickness of the septum.

3. The device of claim 1 wherein the annular gap has a width greater than a thickness of the septum.

4. The device of claim 1 wherein at least one of the first annular flange and the second annular flange is more flexible than the core segment.

5. The device of claim 1 wherein at least one of the first annular flange and the second annular flange comprises a plurality of flange segments.

6. The device of claim 5 wherein at least one of the plurality of flange segments is longer than another one of the flange segments.

7. The device of claim 5 , wherein at least one of said plurality of flange segments comprises a radiopaque marker.

8. The device of claim 1 wherein the device is self-expandable upon deployment.

9. The device of claim 1 wherein the device is balloon-expandable.

10. The device of claim 1 wherein the core segment comprises a substantially open mesh.

11. The device of claim 10 wherein the core segment is comprised of a nonbraided material.

12. The device of claim 1 , wherein said flow control element opens upon an occurrence of a pressure differential between said two sides of said flow control element.

13. The device of claim 12 wherein said flow control element allows fluid to flow through said passage from an area of higher pressure to an area of lower pressure.

14. The device of claim 13 , wherein said pressure differential is at least 2 mm Hg.

15. The device of claim 1 , wherein said flow control element is a valve.

16. The device of claim 15 , wherein said valve comprises at least two leaflets.

17. The device of claim 1 , wherein the flow control element is configured to allow sufficient flow from the left atrium to the right atrium to relieve elevated left atrial pressure.

Assignments (3)
CHANGE OF NAME Recorded Jul 2, 2015
From: DC DEVICES, INC.
To: CORVIA MEDICAL, INC.
Reel/Frame 035973/0741 →
CORRECTIVE ASSIGNMENT TO CORRECT THE THE ASSIGNMENT DOCUMENT PREVIOUSLY RECORDED ON REEL 029853 FRAME 0586. ASSIGNOR(S) HEREBY CONFIRMS THE NAME OF CONVEYING PARTY STEPHEN FORCUCCI. Recorded Jun 25, 2014
From: MCNAMARA, EDWARD; CELERMAJER, DAVID; FORCUCCI, STEPHEN; SUGIMOTO, HIROATSU
To: DC DEVICES, INC.
Reel/Frame 033244/0404 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 21, 2013
From: MCNAMARA, EDWARD; CELERMAJER, DAVID; FORUCCI, STEPHEN; SUGIMOTO, HIROATSU
To: DC DEVICES, INC.
Reel/Frame 029853/0586 →
Continuity (4)
Continuation 12719843 · Mar 8, 2010
Provisional Application 61240085 · Sep 4, 2009
Related Publication 20120289882A1 · Nov 15, 2012
Related Publication 20180099128A9 · Apr 12, 2018
Cited By (12)
US 12,213,817 US 12,303,119 US 12,343,487 US 12,357,792 US 12,440,656 US 12,491,347 US 12,533,500 US 12,544,010 US 12,569,233 US 12,648,787 US 12,661,119 US 12,661,487